Beyond COVID-19 vaccines, RNA therapeutics are revolutionizing the field of medicine: from cancer to infectious diseases to liver/metabolic diseases, the potential is staggering. Yet, what does the investment landscape tell us about where the growth is headed? Our latest infographic highlights the latest trends and data on key nanoparticles, emerging types of RNA, and modified sequences in this evolving space. Share this with your social networks and explore more below.
